222 related articles for article (PubMed ID: 34488619)
1. Reversible dysregulation of renal circadian rhythm in lupus nephritis.
Mishra R; Bethunaickan R; Berthier CC; Yi Z; Strohl JJ; Huerta PT; Zhang W; Davidson A
Mol Med; 2021 Sep; 27(1):99. PubMed ID: 34488619
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.
Klocke J; Ulu A; Wu K; Rudolph B; Dragun D; Gollasch M; Schunck WH; Hammock BD; Riemekasten G; Enghard P
Sci Rep; 2019 Jun; 9(1):8993. PubMed ID: 31222024
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks.
Bethunaickan R; Berthier CC; Zhang W; Kretzler M; Davidson A
PLoS One; 2013; 8(10):e77489. PubMed ID: 24167575
[TBL] [Abstract][Full Text] [Related]
4. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
Knapp J; Braunstein M; Berg SIT; Shirriff C
Arthritis Res Ther; 2022 Dec; 24(1):267. PubMed ID: 36510250
[TBL] [Abstract][Full Text] [Related]
5. Immune cell infiltration characteristics and related core genes in lupus nephritis: results from bioinformatic analysis.
Cao Y; Tang W; Tang W
BMC Immunol; 2019 Oct; 20(1):37. PubMed ID: 31638917
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.
Corradetti C; Jog NR; Cesaroni M; Madaio M; Caricchio R
J Immunol; 2018 Jan; 200(2):512-522. PubMed ID: 29237779
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.
Fu J; Wang Z; Lee K; Wei C; Liu Z; Zhang M; Zhou M; Cai M; Zhang W; Chuang PY; Ma'ayan A; He JC; Liu Z
Kidney Int; 2018 Feb; 93(2):416-429. PubMed ID: 29102373
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic and Epigenetic Alterations in Dendritic Cells Correspond With Chronic Kidney Disease in Lupus Nephritis.
Wardowska A; Komorniczak M; Bułło-Piontecka B; Dȩbska-Ślizień MA; Pikuła M
Front Immunol; 2019; 10():2026. PubMed ID: 31507612
[TBL] [Abstract][Full Text] [Related]
9. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.
Nowling TK; Mather AR; Thiyagarajan T; Hernández-Corbacho MJ; Powers TW; Jones EE; Snider AJ; Oates JC; Drake RR; Siskind LJ
J Am Soc Nephrol; 2015 Jun; 26(6):1402-13. PubMed ID: 25270066
[TBL] [Abstract][Full Text] [Related]
10. Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.
Bethunaickan R; Berthier CC; Zhang W; Eksi R; Li HD; Guan Y; Kretzler M; Davidson A
Arthritis Rheumatol; 2014 Aug; 66(8):2246-2258. PubMed ID: 24757019
[TBL] [Abstract][Full Text] [Related]
11. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
Front Immunol; 2021; 12():653989. PubMed ID: 33868295
[TBL] [Abstract][Full Text] [Related]
12. Glomerular Proteomic Profiles in the NZB/W F1 Hybrid Mouse Model of Lupus Nephritis.
Xue L; Shuyan T; Xiaoli L; Zilong L; Qiuling F; Lining W; Yanqiu L; Li Y
Med Sci Monit; 2019 Mar; 25():2122-2131. PubMed ID: 30900683
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
15. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.
Schiffer L; Sinha J; Wang X; Huang W; von Gersdorff G; Schiffer M; Madaio MP; Davidson A
J Immunol; 2003 Jul; 171(1):489-97. PubMed ID: 12817034
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis.
Nicolaou O; Sokratous K; Makowska Z; Morell M; De Groof A; Montigny P; Hadjisavvas A; Michailidou K; Oulas A; Spyrou GM; Demetriou C; Alarcón-Riquelme ME; Psarellis S; Kousios A; Lauwerys B; Kyriacou K
Arthritis Res Ther; 2020 Jun; 22(1):147. PubMed ID: 32552896
[TBL] [Abstract][Full Text] [Related]
17. Axl regulated survival/proliferation network and its therapeutic intervention in mouse models of glomerulonephritis.
Zhen Y; Ren Y; Medvedovic M; Adams DE; Wang D; Shao WH
Arthritis Res Ther; 2022 Dec; 24(1):284. PubMed ID: 36578056
[TBL] [Abstract][Full Text] [Related]
18. JAK/STAT signaling controls the fate of CD8
Zhou M; Guo C; Li X; Huang Y; Li M; Zhang T; Zhao S; Wang S; Zhang H; Yang N
J Autoimmun; 2020 May; 109():102424. PubMed ID: 32085893
[TBL] [Abstract][Full Text] [Related]
19. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.
Schiffer L; Bethunaickan R; Ramanujam M; Huang W; Schiffer M; Tao H; Madaio MP; Bottinger EP; Davidson A
J Immunol; 2008 Feb; 180(3):1938-47. PubMed ID: 18209092
[TBL] [Abstract][Full Text] [Related]
20. A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.
Bethunaickan R; Berthier CC; Ramanujam M; Sahu R; Zhang W; Sun Y; Bottinger EP; Ivashkiv L; Kretzler M; Davidson A
J Immunol; 2011 Apr; 186(8):4994-5003. PubMed ID: 21411733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
